Crispr gene-editing ‘revolution’ treats internal organ for first time Crispr基因編輯“革命”首次被用于治療內臟
US start-up co-founded by Nobel laureate marks breakthrough over therapies restricted to external cells 美國初創企業Intellia的早期試驗數據標志著Crispr療法取得突破，表明科學家克服了此前僅能將該技術用于編輯體外細胞的局限。